On May 15, 2015, Respironics, Inc., a Philips business, provided the following response to ResMed's Update on Phase IV SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy in Central Sleep Apnea ...
In a study published last September in clinical medical journal Critical Care, Maquet’s SERVO-U ventilator outperformed other ventilators in seven out of nine comparisons on use safety, perceived ...
Amsterdam, the Netherlands – Royal Philips’ (NYSE: PHG, AEX: PHIA) subsidiary, Philips Respironics, today provided an update on the remediation status in the US of the ongoing recall of certain sleep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback